Sichuan Express (00107) net profit attributable to shareholders for the first quarter decreased by 6.06% year-on-year to 4.57 yuan.
Sichuan Chengyu Expressway (00107) released its first quarter report for 2026, with the company achieving operating income of 2.411 billion yuan (same unit below), an increase of 21.25% compared to the same period last year; net profit attributable to shareholders of the listed company was 4.57 yuan, a decrease of 6.06% compared to the same period last year; basic earnings per share were 0.142 yuan.
Sichuan Express (00107) released its first quarter report for 2026, with the company achieving operating income of 2.411 billion yuan (unit same below), a year-on-year increase of 21.25%; net profit attributable to shareholders of the listed company was 4.57 yuan, a year-on-year decrease of 6.06%; basic earnings per share were 0.142 yuan.
Related Articles
ARTA TECHFIN (00279) completes the placement of a total of 123 million shares, raising approximately 59.8 million Hong Kong dollars.
JF SMARTINVEST (09636) repurchased approximately 70,500 shares for about HKD 2.3196 million on April 29th.
CSPC PHARMA (01093): Liposomal Amphotericin B for Injection (HC1507G2) Approved for Marketing Authorization Application in Europe.
ARTA TECHFIN (00279) completes the placement of a total of 123 million shares, raising approximately 59.8 million Hong Kong dollars.
JF SMARTINVEST (09636) repurchased approximately 70,500 shares for about HKD 2.3196 million on April 29th.
CSPC PHARMA (01093): Liposomal Amphotericin B for Injection (HC1507G2) Approved for Marketing Authorization Application in Europe.
RECOMMEND
